EXPION360 INC (XPON) Fundamental Analysis & Valuation

NASDAQ:XPON • US30218B2097

0.71 USD
-0.01 (-1.11%)
At close: Mar 10, 2026
0.7148 USD
+0 (+0.68%)
After Hours: 3/10/2026, 8:00:03 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This XPON fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

XPON gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 91 industry peers in the Electrical Equipment industry. The financial health of XPON is average, but there are quite some concerns on its profitability. XPON has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. XPON Profitability Analysis

1.1 Basic Checks

  • In the past year XPON has reported negative net income.
  • XPON had a negative operating cash flow in the past year.
  • In the past 5 years XPON always reported negative net income.
  • In the past 5 years XPON always reported negative operating cash flow.
XPON Yearly Net Income VS EBIT VS OCF VS FCFXPON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

  • XPON's Return On Assets of -19.18% is in line compared to the rest of the industry. XPON outperforms 46.15% of its industry peers.
  • XPON's Return On Equity of -22.74% is in line compared to the rest of the industry. XPON outperforms 56.04% of its industry peers.
Industry RankSector Rank
ROA -19.18%
ROE -22.74%
ROIC N/A
ROA(3y)-85.26%
ROA(5y)-76.61%
ROE(3y)-246.53%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XPON Yearly ROA, ROE, ROICXPON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -100 -200 -300 -400 -500

1.3 Margins

  • XPON's Gross Margin of 22.35% is in line compared to the rest of the industry. XPON outperforms 47.25% of its industry peers.
  • In the last couple of years the Gross Margin of XPON has declined.
  • The Profit Margin and Operating Margin are not available for XPON so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.45%
GM growth 5YN/A
XPON Yearly Profit, Operating, Gross MarginsXPON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. XPON Health Analysis

2.1 Basic Checks

  • XPON does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • XPON has more shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, XPON has an improved debt to assets ratio.
XPON Yearly Shares OutstandingXPON Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M
XPON Yearly Total Debt VS Total AssetsXPON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

  • XPON has an Altman-Z score of -2.51. This is a bad value and indicates that XPON is not financially healthy and even has some risk of bankruptcy.
  • XPON has a worse Altman-Z score (-2.51) than 68.13% of its industry peers.
  • A Debt/Equity ratio of 0.02 indicates that XPON is not too dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.02, XPON belongs to the best of the industry, outperforming 80.22% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z -2.51
ROIC/WACCN/A
WACC9.04%
XPON Yearly LT Debt VS Equity VS FCFXPON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

  • XPON has a Current Ratio of 9.18. This indicates that XPON is financially healthy and has no problem in meeting its short term obligations.
  • XPON's Current ratio of 9.18 is amongst the best of the industry. XPON outperforms 96.70% of its industry peers.
  • XPON has a Quick Ratio of 5.69. This indicates that XPON is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of XPON (5.69) is better than 90.11% of its industry peers.
Industry RankSector Rank
Current Ratio 9.18
Quick Ratio 5.69
XPON Yearly Current Assets VS Current LiabilitesXPON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. XPON Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 99.31% over the past year.
  • The Revenue has grown by 109.37% in the past year. This is a very strong growth!
  • XPON shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.56% yearly.
EPS 1Y (TTM)99.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.39%
Revenue 1Y (TTM)109.37%
Revenue growth 3Y7.56%
Revenue growth 5YN/A
Sales Q2Q%72.3%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y91.61%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year66.62%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
XPON Yearly Revenue VS EstimatesXPON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
XPON Yearly EPS VS EstimatesXPON Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 -20 -40 -60 -80 -100

More info and screens

Find the best growth stocksShow best growing peers

0

4. XPON Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for XPON. In the last year negative earnings were reported.
  • Also next year XPON is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XPON Price Earnings VS Forward Price EarningsXPON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XPON Per share dataXPON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. XPON Dividend Analysis

5.1 Amount

  • XPON does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

XPON Fundamentals: All Metrics, Ratios and Statistics

EXPION360 INC

NASDAQ:XPON (3/10/2026, 8:00:03 PM)

After market: 0.7148 +0 (+0.68%)

0.71

-0.01 (-1.11%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)01-28
Earnings (Next)N/A
Inst Owners2.72%
Inst Owner Change87.64%
Ins Owners3.02%
Ins Owner Change4.5%
Market Cap6.86M
Revenue(TTM)9.42M
Net Income(TTM)-2.05M
AnalystsN/A
Price TargetN/A
Short Float %8.21%
Short Ratio0.53
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)12.34%
Min Revenue beat(2)-12.53%
Max Revenue beat(2)37.22%
Revenue beat(4)3
Avg Revenue beat(4)14.53%
Min Revenue beat(4)-12.53%
Max Revenue beat(4)37.22%
Revenue beat(8)3
Avg Revenue beat(8)-0.71%
Revenue beat(12)4
Avg Revenue beat(12)-1.34%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.73
P/FCF N/A
P/OCF N/A
P/B 0.76
P/tB 0.76
EV/EBITDA N/A
EPS(TTM)-0.81
EYN/A
EPS(NY)-2.35
Fwd EYN/A
FCF(TTM)-0.69
FCFYN/A
OCF(TTM)-0.69
OCFYN/A
SpS0.97
BVpS0.93
TBVpS0.93
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -19.18%
ROE -22.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.35%
FCFM N/A
ROA(3y)-85.26%
ROA(5y)-76.61%
ROE(3y)-246.53%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.45%
GM growth 5YN/A
F-Score5
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.18
Quick Ratio 5.69
Altman-Z -2.51
F-Score5
WACC9.04%
ROIC/WACCN/A
Cap/Depr(3y)125.7%
Cap/Depr(5y)152.09%
Cap/Sales(3y)2.88%
Cap/Sales(5y)2.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.39%
EPS Next Y91.61%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)109.37%
Revenue growth 3Y7.56%
Revenue growth 5YN/A
Sales Q2Q%72.3%
Revenue Next Year66.62%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year52.84%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-29.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-33.3%
OCF growth 3YN/A
OCF growth 5YN/A

EXPION360 INC / XPON FAQ

What is the ChartMill fundamental rating of EXPION360 INC (XPON) stock?

ChartMill assigns a fundamental rating of 2 / 10 to XPON.


What is the valuation status of EXPION360 INC (XPON) stock?

ChartMill assigns a valuation rating of 0 / 10 to EXPION360 INC (XPON). This can be considered as Overvalued.


How profitable is EXPION360 INC (XPON) stock?

EXPION360 INC (XPON) has a profitability rating of 1 / 10.


What is the expected EPS growth for EXPION360 INC (XPON) stock?

The Earnings per Share (EPS) of EXPION360 INC (XPON) is expected to grow by 91.61% in the next year.